Literature DB >> 23435428

Activation of β-catenin/TCF targets following loss of the tumor suppressor SNF5.

E L Mora-Blanco1, Y Mishina2, E J Tillman1, Y-J Cho3, C S Thom1, S L Pomeroy3, W Shao2, C W M Roberts1.   

Abstract

The SWI/SNF chromatin remodeling complex is a master regulator of developmental cell-fate decisions, although the key target pathways are poorly characterized. Here, we interrogated the contribution of the SWI/SNF subunit and tumor suppressor SNF5 to the regulation of developmental pathways using conditional mouse and cell culture models. We find that loss of SNF5 phenocopies β-catenin hyperactivation and that SNF5 is essential for regulating Wnt/β-catenin pathway target expression. These data provide insight into chromatin-based mechanisms that underlie developmental regulation and elucidate the emerging theme that mutation of this tumor suppressor complex can activate developmental pathways by uncoupling them from upstream control.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23435428      PMCID: PMC4893026          DOI: 10.1038/onc.2013.37

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  38 in total

1.  Influence of FGF4 on digit morphogenesis during limb development in the mouse.

Authors:  V Ngo-Muller; K Muneoka
Journal:  Dev Biol       Date:  2000-03-15       Impact factor: 3.582

2.  Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.

Authors:  Yoon-Jae Cho; Aviad Tsherniak; Pablo Tamayo; Sandro Santagata; Azra Ligon; Heidi Greulich; Rameen Berhoukim; Vladimir Amani; Liliana Goumnerova; Charles G Eberhart; Ching C Lau; James M Olson; Richard J Gilbertson; Amar Gajjar; Olivier Delattre; Marcel Kool; Keith Ligon; Matthew Meyerson; Jill P Mesirov; Scott L Pomeroy
Journal:  J Clin Oncol       Date:  2010-11-22       Impact factor: 44.544

3.  Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice.

Authors:  C J Guidi; A T Sands; B P Zambrowicz; T K Turner; D A Demers; W Webster; T W Smith; A N Imbalzano; S N Jones
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

Review 4.  SWI/SNF nucleosome remodellers and cancer.

Authors:  Boris G Wilson; Charles W M Roberts
Journal:  Nat Rev Cancer       Date:  2011-06-09       Impact factor: 60.716

5.  The chromatin-remodeling enzyme BRG1 modulates vascular Wnt signaling at two levels.

Authors:  Courtney T Griffin; Carol D Curtis; Reema B Davis; Vijay Muthukumar; Terry Magnuson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-24       Impact factor: 11.205

6.  Multiple roles of mesenchymal beta-catenin during murine limb patterning.

Authors:  Theo P Hill; Makoto M Taketo; Walter Birchmeier; Christine Hartmann
Journal:  Development       Date:  2006-02-22       Impact factor: 6.868

7.  Expression of Cre Recombinase in the developing mouse limb bud driven by a Prxl enhancer.

Authors:  Malcolm Logan; James F Martin; Andras Nagy; Corrinne Lobe; Eric N Olson; Clifford J Tabin
Journal:  Genesis       Date:  2002-06       Impact factor: 2.487

8.  Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer.

Authors:  I Versteege; N Sévenet; J Lange; M F Rousseau-Merck; P Ambros; R Handgretinger; A Aurias; O Delattre
Journal:  Nature       Date:  1998-07-09       Impact factor: 49.962

9.  Identification of {beta}-catenin binding regions in colon cancer cells using ChIP-Seq.

Authors:  Daniel Bottomly; Sydney L Kyler; Shannon K McWeeney; Gregory S Yochum
Journal:  Nucleic Acids Res       Date:  2010-05-11       Impact factor: 16.971

10.  PID: the Pathway Interaction Database.

Authors:  Carl F Schaefer; Kira Anthony; Shiva Krupa; Jeffrey Buchoff; Matthew Day; Timo Hannay; Kenneth H Buetow
Journal:  Nucleic Acids Res       Date:  2008-10-02       Impact factor: 16.971

View more
  34 in total

1.  Molecular pathways: SWI/SNF (BAF) complexes are frequently mutated in cancer--mechanisms and potential therapeutic insights.

Authors:  Xiaofeng Wang; Jeffrey R Haswell; Charles W M Roberts
Journal:  Clin Cancer Res       Date:  2013-10-11       Impact factor: 12.531

Review 2.  Atypical teratoid/rhabdoid tumors-current concepts, advances in biology, and potential future therapies.

Authors:  Michael C Frühwald; Jaclyn A Biegel; Franck Bourdeaut; Charles W M Roberts; Susan N Chi
Journal:  Neuro Oncol       Date:  2016-01-10       Impact factor: 12.300

Review 3.  Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth.

Authors:  Kimberly H Kim; Charles W M Roberts
Journal:  Cancer Genet       Date:  2014-04-13

Review 4.  COMPASS and SWI/SNF complexes in development and disease.

Authors:  Bercin K Cenik; Ali Shilatifard
Journal:  Nat Rev Genet       Date:  2020-09-21       Impact factor: 53.242

5.  A Wnt-TGFβ2 axis induces a fibrogenic program in muscle stem cells from dystrophic mice.

Authors:  Stefano Biressi; Elen H Miyabara; Suchitra D Gopinath; Poppy M M Carlig; Thomas A Rando
Journal:  Sci Transl Med       Date:  2014-12-17       Impact factor: 17.956

Review 6.  Molecular biology of pediatric brain tumors and impact on novel therapies.

Authors:  Lindsey M Hoffman; Ralph Salloum; Maryam Fouladi
Journal:  Curr Neurol Neurosci Rep       Date:  2015-04       Impact factor: 5.081

Review 7.  A rationale to target the SWI/SNF complex for cancer therapy.

Authors:  Anja F Hohmann; Christopher R Vakoc
Journal:  Trends Genet       Date:  2014-06-03       Impact factor: 11.639

8.  Genome-Wide Profiles of Extra-cranial Malignant Rhabdoid Tumors Reveal Heterogeneity and Dysregulated Developmental Pathways.

Authors:  Hye-Jung E Chun; Emilia L Lim; Alireza Heravi-Moussavi; Saeed Saberi; Karen L Mungall; Mikhail Bilenky; Annaick Carles; Kane Tse; Inna Shlafman; Kelsey Zhu; Jenny Q Qian; Diana L Palmquist; An He; William Long; Rodrigo Goya; Michelle Ng; Veronique G LeBlanc; Erin Pleasance; Nina Thiessen; Tina Wong; Eric Chuah; Yong-Jun Zhao; Jacquie E Schein; Daniela S Gerhard; Michael D Taylor; Andrew J Mungall; Richard A Moore; Yussanne Ma; Steven J M Jones; Elizabeth J Perlman; Martin Hirst; Marco A Marra
Journal:  Cancer Cell       Date:  2016-03-14       Impact factor: 31.743

Review 9.  Epigenomic regulation of oncogenesis by chromatin remodeling.

Authors:  R Kumar; D-Q Li; S Müller; S Knapp
Journal:  Oncogene       Date:  2016-01-25       Impact factor: 9.867

10.  Wnt pathway in atypical teratoid rhabdoid tumors.

Authors:  Madhavi Chakravadhanula; Chris N Hampton; Parth Chodavadia; Victor Ozols; Li Zhou; Daniel Catchpoole; Jingying Xu; Anat Erdreich-Epstein; Ratan D Bhardwaj
Journal:  Neuro Oncol       Date:  2014-09-21       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.